Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Dent Clin North Am. 2013 Aug 15;57(4):611–630. doi: 10.1016/j.cden.2013.07.003

Table 2.

Presentations of MMP

Sites involved Presentations and potential complications
Skin In 25–30% of patients19
Localized erythematous plaque near affected mucosal surfaces, generalized bullous eruption particularly on the head and upper body, or vegetating lesions occasionally 102, 103
Scarring, cicatricial alopecia on the scalp 104, 105

Oral cavity In over 85% of patients
Desquamative gingivitis, erosions, ulceration (Fig. 1)
Pseudomembrane
Vesicles rarely seen (Fig. 2), bleeding
Pain and inability to eat certain types of food
Self-limiting mostly
Mild scarring or atrophy, intraoral adhesion, loss of teeth rarely

Eye The second most common site (in 65% of patients) 106
Nonspecific conjunctivitis
Erosions, corneal damage
Photophobia and photosensitivity, dryness
Progressive process leading to scarring
Symblepharon (Fig. 4), ankyloblepharon, trichiasis, entropion
Blindness in close to 15% of patients

Nose In 20–40% of patients
Discharge, erosion, excessive crust
Scarring
Breathing difficulty

Larynx In 5–15% of patients
Sore throat, hoarseness
Scarring, stenosis of airway
Breathing difficulty

Esophagus In 5–15% of patients
Dysphagia, odynophagia, esophageal reflux
Stricture formation
Disability in eating
Death

Anogenital area In 20% of patients
Erosion and ulceration
Bleeding
Pain
Dysuria
Sexual dysfunction